Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 341

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

The Use of Exhaled Nitric Oxide to Guide Asthma Management: A Randomized Controlled Trial

Open access
Shaw, Dominick E., Berry, Mike A., Thomas, Mike, Green, Ruth H., Brightling, Chris E., Wardlaw, Andrew J., Pavord, Ian D.·2007·American Journal of Respiratory and Critical Care Medicine

Abstract

RATIONALE: Current asthma guidelines recommend adjusting antiinflammatory treatment on the basis of the results of lung function tests and symptom assessment, neither of which are closely associated with airway inflammation. OBJECTIVES: We tested the hypothesis that titrating corticosteroid dose using the concentration of exhaled nitric oxide in exhaled breath (Fe(NO)) results in fewer asthma exacerbations and more efficient use of corticosteroids, when compared with traditional management. METHODS: One hundred eighteen participants with a primary care diagnosis of asthma were randomized to a single-blind trial of corticosteroid therapy based on either Fe(NO) measurements (n = 58) or British Thoracic Society guidelines (n = 60). Participants were assessed monthly for 4 months and then every 2 months for a further 8 months. The primary outcome was the number of severe asthma exacerbations. Analyses were by intention to treat. MEASUREMENTS AND MAIN RESULTS: The estimated mean (SD) exacerbation frequency was 0.33 per patient per year (0.69) in the Fe(NO) group and 0.42 (0.79) in the control group (mean difference, -21%; 95% confidence interval [CI], -57 to 43%; p = 0.43). Overall the Fe(NO) group used 11% more inhaled corticosteroid (95% CI, -17 to 42%; p = 0.40), although the final daily dose of inhaled corticosteroid was lower in the Fe(NO) group (557 vs. 895 microg; mean difference, 338 microg; 95% CI, -640 to -37; p = 0.028). CONCLUSIONS: An asthma treatment strategy based on the measurement of exhaled nitric oxide did not result in a large reduction in asthma exacerbations or in the total amount of inhaled corticosteroid therapy used over 12 mo, when compared with current asthma guidelines. Clinical trial registered with www.controlled-trials.com (ISRCTN08067387).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1164/rccm.200610-1427oc

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 341

Metadata

Authors
Shaw, D. E., Berry, M. A., Thomas, M., Green, R. H., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D.
Venue
American Journal of Respiratory and Critical Care Medicine
Published
2007-08-01
Volume
176
Issue
3
Pages
231-237
ISSN
  • 1073-449X (ISSN-L)
  • 1535-4970
OpenAlex
W1953300272
Cited by
341
References
27
FWCI
26.30
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Use of Exhaled Nitric Oxide to Guide Asthma Management: A Randomized Controlled Trial. https://app.cochat.ai/papers/10.1164/rccm.200610-1427oc
The paper
Shaw, D. E., Berry, M. A., Thomas, M., Green, R. H., Brightling, C. E., Wardlaw, A. J., & Pavord, I. D. (2007). The Use of Exhaled Nitric Oxide to Guide Asthma Management: A Randomized Controlled Trial. American Journal of Respiratory and Critical Care Medicine. https://doi.org/10.1164/rccm.200610-1427oc

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.